Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2007
At a glance
- Drugs Mecamylamine (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Oct 2007 New trial record.